ORBIMED ADVISORS LLC

Fund / adviser Identified by SEC record CIK 1055951

Each row is one ownership form naming ORBIMED ADVISORS LLC as an owner of a listed company’s stock.

Everything below comes from forms this entity filed with the US Securities and Exchange Commission — not an estimate, not a survey, and not a valuation.

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

25 companies it discloses a stake in
0 filings naming it as owned
25 of those stakes filed jointly

Read the share counts carefully. 25 of these 25 stakes were reported on filings shared with other entities.

What that does to the share counts

On a joint filing every named filer is listed against the whole position, so the same block of stock also appears under the other names. Adding those figures together would invent stock that does not exist. Joint positions are marked joint wherever they appear, and nothing on this site sums a position across owners.

Ownership map

What ORBIMED ADVISORS LLC holds, and what those companies hold in turn. A name in plain text is the end of the trail: we hold the filing that names it, but no separate record to open.

ORBIMED ADVISORS LLC
This map is not ordered by size.

It draws at most eight holdings per level and stops after two levels, showing the holdings we can follow further first, not the largest ones — for every position in order of size, read the table below. Entities that own each other are drawn once: a chain never doubles back on a name it has already passed through.

Holds stakes in

Every company this entity has filed on, largest reported position first. Each row links to the filing it came from.

Companies in which ORBIMED ADVISORS LLC discloses an ownership position, with the size of that position and the filing it was taken from.
Company Reported role Shares Filed Filing
Enliven Therapeutics, Inc. ELVN Director,Other,TenPercentOwner 7,663,349 joint 4
Corvus Pharmaceuticals, Inc. CRVS Director,Other,TenPercentOwner 7,165,006 joint 4
Passage BIO, Inc. PASG Director,Other,TenPercentOwner 6,066,343 joint 4
PMV Pharmaceuticals, Inc. PMVP Director,Other,TenPercentOwner 4,975,291 joint 4
Upstream Bio, Inc. UPB Director,Other,TenPercentOwner 4,554,873 joint 4
Adicet Bio, Inc. ACET Director,Other,TenPercentOwner 4,490,254 joint 4
Sionna Therapeutics, Inc. SION Director,Other,TenPercentOwner 3,530,702 joint 4
NeuroPace Inc NPCE Director,Other,TenPercentOwner 3,238,199 joint 4
Lomond Therapeutics Holdings, Inc. Director,Other,TenPercentOwner 2,677,256 joint 4
TELA Bio, Inc. TELA Director,Other,TenPercentOwner 2,407,242 joint 4
Shattuck Labs, Inc. STTK Director,Other,TenPercentOwner 1,051,021 joint 4
Terns Pharmaceuticals, Inc. TERN Director,Other,TenPercentOwner 755,635 joint 4
MBX Biosciences, Inc. MBX Director,Other,TenPercentOwner 747,887 joint 4
Traws Pharma, Inc. TRAW Director,Other,TenPercentOwner 602,000 joint 3
Edgewise Therapeutics, Inc. EWTX Director,Other,TenPercentOwner 443,792 joint 4
ImageneBio, Inc. IMA Director,Other,TenPercentOwner 287,885 joint 4
scPharmaceuticals Inc. SCPH Director,Other,TenPercentOwner 252,858 joint 4
Disc Medicine, Inc. IRON Director,Other,TenPercentOwner 186,541 joint 4
Keros Therapeutics, Inc. KROS Director,Other,TenPercentOwner 45,057 joint 4
ALPINE IMMUNE SCIENCES, INC. ALPN Director,Other,TenPercentOwner 0 joint 4
ARS Pharmaceuticals, Inc. SPRY Director,Other,TenPercentOwner 0 joint 4
Compass Therapeutics, Inc. CMPX Director,Other,TenPercentOwner 0 joint 4
Kinnate Biopharma Inc. KNTE Director,Other,TenPercentOwner 0 joint 4
Turnstone Biologics Corp. TSBX Director,Other,TenPercentOwner 0 joint 4
Xtant Medical Holdings, Inc. XTNT Director,Other,TenPercentOwner 0 joint 4

How to read this page

Full methodology · All entities that file as owners